PD
IONS icon

Point72 (DIFC)’s Ionis Pharmaceuticals IONS Stock Holding History

Point72 (DIFC)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.03M Buy
15,698
+7,611
+94% +$372K 0.07% 181
2025
Q2 		$320K Sell
8,087
-33,260
-80% -$1.09M 0.01% 684
2025
Q1 		$1.25M Buy
+41,347
New +$1.35M 0.05% 414
2024
Q3 		– Sell
-4,694
Closed -$224K – 1638
2024
Q2 		$224K Sell
4,694
-23,797
-84% -$976K 0.01% 830
2024
Q1 		$1.24M Buy
+28,491
New +$1.36M 0.04% 518

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s IONS Position: Q3 2025 in Review

Point72 (DIFC) increased its Ionis Pharmaceuticals (IONS) stake by 94% in Q3 2025, buying an estimated $372K and bringing the position to 15,698 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #181.

Point72 (DIFC) first reported a position in IONS in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.25M in Q1 2025. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Point72 (DIFC) held 15,698 shares of Ionis Pharmaceuticals worth $1.03M as of Q3 2025.
  • Point72 (DIFC) bought 7,611 Ionis Pharmaceuticals shares in Q3 2025, an estimated $372K.
  • Ionis Pharmaceuticals made up 0.07% of Point72 (DIFC)'s portfolio in Q3 2025, its #181 holding.
  • Point72 (DIFC) first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Point72 (DIFC)'s Ionis Pharmaceuticals position peaked at $1.25M in Q1 2025.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.